Stada Arzneimittel Ag competitive analysis

Explore patent oppositions filed by Stada Arzneimittel Ag against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Mar 26, 2026
Patent NumberTitleApplicantOpposition Date
Biomarkers For A Therapy Comprising A Sorafenib CompoundEISAI R&D MANAGEMENTOct 8, 2025
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 18, 2025
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
Apixaban FormulationsBRISTOL MYERS SQUIBBDec 19, 2024
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024
Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICASep 5, 2024
Tumor-Treating Pharmaceutical CompositionEISAI R&D MANAGEMENTAug 29, 2024

Explore Stada Arzneimittel Ag's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Mar 26, 2026
Patent NumberPublication DateTitleTotal Oppositions
Sep 28, 2022Method For Producing A Bortezomib Ester Solution6
Aug 17, 2022Ready-To-Use Bortezomib Solution7
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations6
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations9

Latest PTAB cases involving Stada Arzneimittel Ag

Discover the latest PTAB cases involving Stada Arzneimittel Ag, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Stada Arzneimittel Ag with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 26, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
STADA ARZNEIMITTEL11128 - -
BOEHRINGER INGELHEIM49181109
NOVARTIS6441 - 21
PFIZER53944412